Papillary thyroid cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of papillary thyroid cancer include elevated T3, elevated T4, decreased [[thyroid stimulating hormone]], and presence of tumor markers such as thyroglobulin, | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
[[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.<ref name="pmid18060877">{{cite journal |author=Lin JD |title=Thyroglobulin and human thyroid cancer |journal=Clin Chim Acta |volume= 388|issue= 1–2|pages= 15–21|year=2007 |pmid=18060877 |doi=10.1016/j.cca.2007.11.002}}</ref><ref name="pmid17673127">{{cite journal |author=Tuttle RM, Leboeuf R, Martorella AJ |title=Papillary thyroid cancer: monitoring and therapy |journal=Endocrinol. Metab. Clin. North Am. |volume=36 |issue=3 |pages=753–78, vii |year=2007 |pmid=17673127 |doi=10.1016/j.ecl.2007.04.004}}</ref> | [[Thyroglobulin]] can be used as a [[tumor marker]] for well-[[Cellular differentiation|differentiated]] papillary thyroid cancer.<ref name="pmid18060877">{{cite journal |author=Lin JD |title=Thyroglobulin and human thyroid cancer |journal=Clin Chim Acta |volume= 388|issue= 1–2|pages= 15–21|year=2007 |pmid=18060877 |doi=10.1016/j.cca.2007.11.002}}</ref><ref name="pmid17673127">{{cite journal |author=Tuttle RM, Leboeuf R, Martorella AJ |title=Papillary thyroid cancer: monitoring and therapy |journal=Endocrinol. Metab. Clin. North Am. |volume=36 |issue=3 |pages=753–78, vii |year=2007 |pmid=17673127 |doi=10.1016/j.ecl.2007.04.004}}</ref> | ||
Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref> | Reduced expression of [[ATP5E]] is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.<ref>{{cite journal|last1=Hurtado-López|first1=LM|last2=Fernández-Ramírez|first2=F|last3=Martínez-Peñafiel|first3=E|last4=Carrillo Ruiz|first4=JD|last5=Herrera González|first5=NE|title=Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?|journal=Medical science monitor : international medical journal of experimental and clinical research|date=16 June 2015|volume=21|pages=1745-51|pmid=26079849}}</ref> | ||
==References== | ==References== | ||
Revision as of 21:18, 5 November 2015
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer laboratory findings |
|
Risk calculators and risk factors for Papillary thyroid cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of papillary thyroid cancer include elevated T3, elevated T4, decreased thyroid stimulating hormone, and presence of tumor markers such as thyroglobulin,
Laboratory Findings
Thyroglobulin can be used as a tumor marker for well-differentiated papillary thyroid cancer.[1][2] Reduced expression of ATP5E is significantly associated with the diagnosis of papillary thyroid cancer and may serve as an early tumor marker of the disease.[3]
References
- ↑ Lin JD (2007). "Thyroglobulin and human thyroid cancer". Clin Chim Acta. 388 (1–2): 15–21. doi:10.1016/j.cca.2007.11.002. PMID 18060877.
- ↑ Tuttle RM, Leboeuf R, Martorella AJ (2007). "Papillary thyroid cancer: monitoring and therapy". Endocrinol. Metab. Clin. North Am. 36 (3): 753–78, vii. doi:10.1016/j.ecl.2007.04.004. PMID 17673127.
- ↑ Hurtado-López, LM; Fernández-Ramírez, F; Martínez-Peñafiel, E; Carrillo Ruiz, JD; Herrera González, NE (16 June 2015). "Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?". Medical science monitor : international medical journal of experimental and clinical research. 21: 1745–51. PMID 26079849.